Chronic ischemic stroke model in cynomolgus monkeys: Behavioral, neuroimaging and anatomical study

Neurological Research

Volumn 25, Issue 1, 2003, Pages 68-78

  Roitberg, Ben ^a   Khan, Naimath ^a   Tuccar, Eray ^a   Kompoliti, Katie ^b   Chu, Yaping ^b   Alperin, Noam ^a   Kordower, Jeffrey H ^b   Emborg, Marina E ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Behavior; Middle cerebral artery; MR spectroscopy; Nonhuman primates; Stroke

Indexed keywords

CELL MARKER; CREATININE; N ACETYLASPARTIC ACID; PROTEIN NEUN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANIMAL USE; ARTICLE; BEHAVIOR; BIOCHEMISTRY; BODY POSTURE; BRAIN INFARCTION; CELL LOSS; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MODEL; FOLLOW UP; HEMIANOPIA; HEMIPARESIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACACA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR ACTIVITY; MOTOR PERFORMANCE; NERVE CELL; NEUROANATOMY; NISSL STAINING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL DENSITY; PRIMATE; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; REPRODUCIBILITY; ROTATION; STEM CELL TRANSPLANTATION; TASK PERFORMANCE;

ANIMALS; ASPARTIC ACID; BRAIN; BRAIN ISCHEMIA; CHRONIC DISEASE; FOLLOW-UP STUDIES; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MACACA FASCICULARIS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, ANIMAL; MOTOR SKILLS;

EID: 0037240633     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164103101200950     Document Type: Article

References (37)

1. Goldstein LB, Adams R, Becker K, Furberg C, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ. Primary prevention of ischemic stroke. A statement for healthcare professionals from the stroke council of the American Heart Association. Stroke 2001; 32: 280-299
2. Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander L, Rader D, Ross JL, Raps E, Ozer MN, Brass LM, Malone ME, Goldberg S, Booss J, Hanley DF, Toole JF, Greengold NL, Rhew DC. Prevention of a first stroke. A review of guidelines and multidisciplinary consensus statement from the National Stroke Association. JAMA 1999; 281: 1112-1120
3. Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR. Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol 1998; 149: 310-321
4. Lawrence MS, McLaughlin JR, Sun GH, Ho DY, McIntosh L, Kunis DM, Sapolsky RM, Steinberg GK. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. J Cereb Blood Flow Metab 1997; 17: 740-744
5. Crowell RM, Olsson Y, Klatzo I, Ommaya A. Temporary occlusion of the middle cerebral artery in the monkey: Clinical and pathological observations. Stroke 1970; 1: 439-448
6. Yonas H, Gur D, Claassen D, Wolfson SK Jr, Moossy J. Stable xenon enhanced computed tomography in the study of clinical and pathologic correlates of focal ischemia in baboons. Stroke 1988; 19: 228-238
7. Henry PT, Chandy MJ. Effect of ascorbic acid on infarct size in experimental focal cerebral ischemia and reperfusion in a primate model. Acta Neurochir (Wien) 1998; 140: 977-980
8. Takamatsu H, Tsukada H, Kakiuchi T, Nishiyama S, Noda A, Umemura K. Detection of reperfusion injury using PET in a monkey model of cerebral ischemia. J Nucl Med 2000; 41: 1409-1416
9. Kito G, Nishimura A, Susumu T, Nagata R, Kuge Y, Yokota C, Minematsu K. Experimental thromboembolic stroke in cynomolgus monkey. J Neurosci Meth 2001; 105: 45-53
10. Auer RN, Coupland SG, Jason GW, Archer DP, Payne J, Belzberg AJ, Ohtaki M, Tranmer BI. Postischemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischemia. Mol Chem Neuropathol 1996; 29: 193-210
11. Frazee JG, Luo X, Luan G, Hinton DS, Hovda DA, Shiroishi MS, Barcliff LT. Retrograde transvenous neuroperfusion: A back door treatment for stroke. Stroke 1998; 29: 1912-1916
12. Young AR, Touzani O, Derlon JM, Sette G, MacKenzie ET, Baron JC. Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion: A quantitative analysis of infarction volume. Stroke 1997; 28: 632-638
13. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR 1996; 17: 1-15
14. Federico F, Simone II, Lucivero V, Giannini P, Laddomada G, Mezzapesa DM, Tortorella C. Prognostic value of proton magnetic resonance spectroscopy in ischemic stroke. Arch Neurol 1998; 55: 489-494
15. Brand A, Richter-Landsherg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289-298
16. Dreher W, Kuhn B, Gyngell ML, Busch E, Niendorf T, Hossmann KA, Leibfritz D. Temporal and regional changes during focal ischemia in rat brain studied by proton spectroscopic imaging and quantitative diffusion NMR imaging. Magn Reson Med 1998; 39: 8778-8888
17. 1H magnetic resonance spectroscopy of cerebral ischemia in rats. J Biochem Cell Biol 1998; 76: 487-496
18. Norris DG, Hoen-Berlage M, Dreher W, Kohno K, Busch E, Schmitz B. Characterization of middle cerebral artery occlusion infarct development in the rat using fast nuclear magnetic resonance proton spectroscopic imaging and diffusion-weighted imaging. J Cereb Blood Flow Metab 1998; 18: 749-757
19. Sager TN, Laursen H, Fink-Jensen A, Topp S, Stensgaard A, Hedehus M, Rosenbaum S, Valsborg JS, Hansen AJ. N-Acetyl-aspartate distribution in rat brain striatum during acute brain ischemia. J Cereb Blood Flow Metab 1999; 19: 164-172
20. Wardlaw JM, Marshall I, Wild J, Dennis MS, Cannon J, Lewis SC. Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: Relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. Stroke 1998; 29: 1618-1624
21. Monsein LH, Mathew VP, Barker PB Pardo CA, Blackband SJ, Whitlow WD, Wong DF, Bryan RN. Irreversible regional cerebral ischemia: Serial MR imaging and proton MR spectroscopy in a nonhuman primate model. AJNR 1993; 14: 963-970
22. Handa Y, Kaneko M, Matuda T, Kobayashi H, Kubota T. In vivo proton magnetic resonance spectroscopy for metabolic changes in brain during chronic cerebral vasospasm in primates. Neurosurgery 1997; 40: 773-790
23. Graham GD, Blamire AM, Rothman DL, Brass LM, Fayad PB, Petroff OA, Prichard JW. Early temporal variation of cerebral metabolites after human stroke. A proton magnetic resonance spectroscopy study. Stroke 1993; 24: 1891-1896
24. Gideon P, Sperling B, Arlien-Soborg P, Olsen TS, Henriksen O. Long-term follow-up of cerebral infarction patients with proton magnetic resonance spectroscopy. Stroke 1994; 25: 967-973
25. Houkin K, Kamada K, Kamiyama H, Iwasaki Y, Abe H, Kashiwaba T. Longitudinal changes in proton magnetic resonance spectroscopy in cerebral infarction. Stroke 1993; 24: 1316-1321
26. Laurent JP, Molinari GF, Moseley JI. Clinicopathological validation of a primate stroke model. Surg Neurol 1975; 4: 449-455
27. Marshall JW, Cross AJ, Jackson DM, Green AR, Baker HF, Ridley RM. Clomethiazole protects against hemineglect in a primate model of stroke. Brain Res Bull 2000; 5291: 21-29
28. Emborg ME, Ma SY, Mufson EJ, Levey AI, Taylor MD, Brown WD, Holden JE, Kordower JH. Age-related declines in nigral neuronal function correlate with motor impairment in rhesus monkeys. J Comp Neurol 1998; 401: 253-265
29. Roitberg BZ, Emborg ME, Sramek JG, Palfi S, Kordower JH. Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease. Neurosurgery 2002; 50: 137-147
30. Palfi S, Conde F, Riche D, Brouillet E, Dautry C, Mittoux V, Chibois A, Peschanski M, Hantraye P. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington's disease. Nature Medicine 1998; 4: 963-966
31. Chu Y, Cochran EJ, Bennett DA, Mufson EJ, Kordower JH. Downregulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 2001; 437: 296-307
32. Mullen RJ, Buck CR, Smith AM. NeuN, a neuronal specific nuclear protein in vertebrates. Development 1992; 116: 201-211
33. Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, Jannetta P, DeCesare S, Elder EM, McGrogan M, Reitman MA, Bynum I. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000; 55: 565-569
34. Emborg ME, Kordower JH. Delivery of therapeutic molecules into the CNS. Prog Brain Res 2000; 128: 323-332
35. Grabowski M, Brundin P, Johansson BB. Functional integration of cortical grafts placed in brain infarcts of rats. Ann Neurol 1993; 34: 362-368
36. Mattsson B, Sorensen JC, Zimmer J, Johansson BB. Neural grafting to experimental neocortical infarcts improves behavioral outcome and reduces thalamic atrophy in rats housed in enriched but not in standard environments. Stroke 1997; 28: 1225-1231
37. Nishino H, Czurko A, Onizuka K, Fukuda A, Hida H, Ungsuparkorn C, Kunimatsu M, Sasaki M, Karadi Z, Lenard L. Neuronal damage following transient cerebral ischemia and its restoration by neural transplant. Neurobiology (Bp) 1994; 2: 223-234